Study guide
PET/CT Anatomy, Physiology and Attenuation Correction
NMTCB CT
Track your progress as you read
Finished sections get a check mark.
1 CT System Hardware & X-Ray Generation
X-Ray Tube Design and Focal Spots Tube Heat Loading, Bearings and Cooling Beam Filtration and Collimation Scanner Generations and Source/Detector Geometry Detector Technology & Data Acquisition Systems (DAS)
2 Gantry Mechanics & Ancillary Systems
Gantry Architecture, Clearance and Centering Slip Rings, Couch Motion and Load Safety Power Injector Hardware and Safety DICOM, Worklists and Image Archiving
3 Data Acquisition & Scanning Geometries
Axial vs. Helical Scanning & Pitch Mechanics Localizer/Scout Scans & Isocenter Alignment Beam Geometry, Slice Collimation & Data Sampling
4 Mathematical Reconstruction & Image Processing
Projection Data, Image Matrices and Voxel Sampling Filtered Back Projection and Reconstruction Kernels Iterative Reconstruction & AI-Powered Algorithms Hounsfield Unit Scale, Linear Attenuation & Windowing (WW/WL)
5 3D Visualization & Advanced Post-Processing
Multiplanar Reformation (MPR) & Curved Planar Reformation (CPR) Volume Rendering, Maximum/Minimum Intensity Projections & Virtual Endoscopy
6 Image Quality & Performance Metrics
Spatial Resolution, Modulation Transfer Function & Matrix Parameters MTF and Spatial-Resolution Testing Contrast Resolution, Quantum Noise & Temporal Resolution Interdependence of Image Quality Parameters & Radiation Dose
7 CT Artifacts Identification & Correction
Physics-Based Artifacts: Beam Hardening, Cupping & Partial Volume Averaging Equipment & Patient Artifacts: Ring, Motion, Metal & Windmill Effects
8 Quality Assurance & Routine Testing
Daily Quality Control: Water Calibration, Noise & Field Uniformity Periodic Quality Assurance: ACR Phantom Testing & Geometry Verification
9 Patient Communication, Screening & Preparation
Patient Identification, Clinical Screening & Pregnancy Protocols Informed Consent, Pre-Scan Fasting & Anxiety Management Patient Monitoring, Vital Signs Assessment & ECG Gating Setup
10 Infection Control & Medical Emergency Response
Infection Control, Aseptic Technique & Scanner Disinfection Medical Emergencies in the CT Suite: Vasovagal Reactions, Seizures & Code Protocols
11 Contrast Media Chemistry & Administration
Iodinated Contrast Properties: Osmolality, Viscosity & Molecular Structure Contrast Volume, Flow, Duration and Iodine Delivery Intravenous Access, Catheter Gauges & Power Injection Protocols Bolus Tracking, Test Bolus & Contrast Transit Dynamics
12 Non-Vascular Contrast & Adverse Reactions
Oral, Rectal and Enteral Contrast Intrathecal, Intra-articular and Cavitary Contrast Renal Impairment, CI-AKI Risk & Metformin Management Contrast Reactions: Categorization, Prophylaxis & Emergency Treatment
13 Neuroimaging & Head/Neck CT Protocols
Routine Brain and Trauma CT Technique Stroke, Hemorrhage and Targeted Skull-Base CT Facial Bones, Orbits & High-Resolution Temporal Bones Soft Tissue Neck & Paranasal Sinuses Protocols
14 Thoracic & Cardiovascular CT Protocols
Routine Chest CT: Pulmonary Parenchyma & Mediastinal Anatomy High-Resolution CT (HRCT) for Diffuse Interstitial Lung Disease Pulmonary Embolism & Cardiac CT Protocols
15 Abdominal & Pelvic CT Protocols
Multiphase Liver, Pancreas & Renal CT Protocols Gastrointestinal CT: Enterography, Colonography & Acute Abdomen Pelvic Cross-Sectional Anatomy & Gynecologic/Urologic Pathology
16 Musculoskeletal, Vascular & Interventional CT
Cervical, Thoracic and Lumbosacral Spine CT Extremity, Joint and Orthopedic Hardware CT CT Angiography (CTA): Carotid, Aortic & Peripheral Runoff Protocols CT-Guided Interventions: Biopsy, Abscess Drainage & Procedural Safety
17 Hybrid PET/CT and SPECT/CT Procedures
PET/CT Anatomy, Physiology and Attenuation Correction SPECT/CT Anatomy, Physiology and Attenuation Correction
18 Radiation Biology & Dose Descriptors
Radiation Physics, Cellular Interactions & Biological Risk Models Tissue Reactions, Stochastic Risk and Justification CTDI Measurement and Phantom References CTDI Weighting, Pitch and DLP Calculations Size-Specific Dose Estimates Effective-Dose Estimates and Diagnostic Reference Levels
19 Radiation Protection & Dose Optimization
Technical Dose Reduction: Tube Current Modulation & Pediatric ALARA Pediatric, Body-Habitus and Pregnancy Optimization Personnel Protection, Distance and Shielding Jurisdiction, Dose Limits and Personnel Monitoring
PET/CT Anatomy, Physiology and Attenuation Correction
Key Takeaways Explain This Topic AI
PET uptake represents tracer physiology rather than anatomy alone.
CT attenuation data must be converted for PET photon energy.
Respiratory misregistration can alter attenuation-corrected uptake.
Last updated: October 2026
Separate the two signals in PET/CT
Positron emission tomography/computed tomography (PET/CT) combines a map of radiopharmaceutical distribution with x-ray anatomy. PET detects paired annihilation photons associated with positron emission; CT measures transmitted x-rays. The fused display relates functional uptake to an anatomical structure. A bright PET focus is not automatically a tumor, and a CT abnormality can be important even when it has little tracer uptake.
For the NMTCB CT outline, study the anatomy, physiology, organ-system relationships and attenuation-correction role of CT in the hybrid examination. The CT component may be a low-dose attenuation/localization scan or a diagnostic examination with appropriate image quality and, when indicated, contrast. Those purposes require different acquisition choices. A low-dose localization image does not automatically replace an ordered diagnostic chest or abdominal CT.
Anatomy and organ-system correlation
Use CT to locate uptake in the brain, neck, mediastinum, lungs, liver, bowel, urinary system, skeleton and soft tissues. Distinguish an intrapulmonary focus from a mediastinal node, a bowel focus from an adjacent pelvic node, and a vertebral focus from paraspinal muscle. Inspect axial data with coronal and sagittal views rather than relying only on a rotating PET maximum-intensity projection.
With fluorodeoxyglucose (FDG), normal brain glucose metabolism produces substantial cerebral uptake. Renal excretion commonly produces activity in the kidneys, ureters and bladder. Myocardial and bowel uptake can vary. Muscle use, inflammation and brown adipose tissue can create nonmalignant uptake. These physiologic examples teach why localization matters: an apparent neck node on PET may correspond to activated muscle or brown fat on CT. Other tracers have different biodistributions, so FDG rules must not be applied to every PET agent.
Preparation affects physiology and quantification
FDG imaging uses preparation intended to stabilize the metabolic conditions relevant to the study, including the prescribed fasting, glucose assessment and activity restrictions. This fasting is an FDG protocol requirement, not evidence that every intravenous iodinated contrast examination requires fasting. Record glucose, uptake time, administered activity, injection issues and the information required by the nuclear medicine protocol.
An infiltrated radiopharmaceutical injection can alter delivered activity and quantitative interpretation. Recent therapy, infection, surgery or vigorous activity can change distribution. The technologist should communicate these circumstances so that they are considered when comparing uptake between studies. A change in uptake is not interpretable solely from a displayed numerical value if preparation, timing or reconstruction differ substantially.
CT-based attenuation correction
PET photons can be absorbed or scattered before reaching the detectors. CT provides a spatial map from which the system estimates attenuation at the PET photon energy. The scanner transforms diagnostic-energy CT information to an attenuation map suitable for 511 keV photons. CT HU values are not directly the 511 keV attenuation coefficient, and the transformation must account for tissue behavior.
The attenuation map is used during PET reconstruction to compensate for location-dependent photon loss. It supports quantitative accuracy, but it cannot correct an inaccurate map or a misregistered patient automatically. CT truncation, metal and dense contrast can affect the map and create an apparent uptake abnormality. Inspect non-attenuation-corrected PET when a focus may be a correction artifact; compare the CT and corrected PET before accepting the fused finding.
Respiratory and positional registration
CT is acquired quickly, whereas PET emission data average motion over a longer interval. A deep inspiratory diagnostic chest CT can place the diaphragm differently from the PET data. Misregistration near the lung bases or liver dome can shift apparent lesion location and distort attenuation correction. The attenuation/localization CT often uses shallow or tidal breathing according to the validated protocol, with a separate diagnostic inspiratory series when required.
Keep the patient in a reproducible position and avoid movement between components. Arms above the head may reduce torso streaking when tolerated; arms down may be needed for head/neck tasks or patient limitations. Do not sacrifice safety or force painful positioning to obtain the ideal arrangement. Check registration before the patient leaves when the workflow permits correction of a meaningful problem.
- Observed problem Possible explanation Useful review
- Focus near a metal implant only on corrected PET Attenuation-map artifact CT and noncorrected PET
- Lung-base focus appears in the liver on fusion Respiratory mismatch Diaphragm alignment on multiple planes
- Pelvic activity follows a tubular structure Urinary excretion CT ureter course and adjacent tissues
Changed uptake between examinations Physiology or technique as well as disease Preparation, uptake interval and reconstruction
Contrast and dose planning
A diagnostic contrast-enhanced CT may be combined with PET/CT under an approved strategy. Dense oral or intravascular contrast can affect attenuation correction, with the magnitude dependent on the system and protocol. Contrast is not universally prohibited. Verify which CT series supplies the attenuation map and which supplies diagnostic interpretation, and use the validated acquisition order.
The patient receives radiation from both the radiopharmaceutical and CT. CTDIvol and DLP describe the CT component, not the administered tracer dose. Avoid duplicating a diagnostic CT already available when the responsible team can use it appropriately, but do not assume an older scan can supply a current attenuation map without validated registration. Document each component's purpose, technique, limitations and administered materials.
References: EANM FDG PET/CT guideline 2.0 , SNMMI/EANM brain FDG PET standard 2.0 .